Month: June 2022

NEW YORK, June 30, 2022 (GLOBE NEWSWIRE) — Minerals Technologies Inc. (NYSE: MTX) (“MTI” or “the Company”) today announced that Rocky Motwani has been elected to its Board of Directors. “Rocky is an accomplished business leader, with more than 20 years of experience in financial services, technology and entrepreneurship, and we are pleased to welcome him to our Board,” said Douglas T. Dietrich, Chairman and Chief Executive Officer. “Mr. Motwani brings fresh perspectives and a diverse set of skills from multiple sectors that will further deepen and broaden the expertise of MTI’s Board.” Mr. Motwani began his career at JLL, a firm that specializes in real estate and investment management. He then moved to McKinsey & Company, serving the technology sector in Silicon Valley. He held senior roles at J.P. Morgan, including Managing...

LEXINGTON, Mass., June 30, 2022 (GLOBE NEWSWIRE) — Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of therapeutics designed to activate the immune response to cancers and infections, today announced that Dr. Steven O’Day, Chief Medical Officer, will participate in a panel discussion on developing therapies for the next immuno-oncology targets at William Blair’s Biotech Focus Conference on Tuesday, July 12, 2022, at 4:10 PM EST. The Conference will be held at The St. Regis New York hotel from July 12th – 13th, during which Agenus will also host one-on-one meetings with investors. About AgenusAgenus is a clinical-stage immuno-oncology company focused on the discovery and development of therapies that engage the body’s immune system to fight cancer and infections. The Company’s vision is to...

In line with the objective for the share buy-back programme which was executed by Equinor ASA (OSE: EQNR, NYSE: EQNR) in three tranches in the period 28 July 2021 until 25 March 2022, the annual general meeting on 11 May 2022 in Equinor ASA decided that the share capital shall be reduced with NOK 205,543,870 from NOK 8,144,219,267.50 to NOK 7,938,675,397.50, by deletion or redemption of total 82,217,548 shares. The creditor deadline for the capital reduction has expired and the capital reduction was completed in the Company Register Center 29 June 2022.  Further information: Investor relations: Mads Holm, senior vice president, Treasury & Tax, and Investor Relations, +47 909 55 417 (mobile) This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act

Multitude Group publishes its first ESG Policy Helsinki, 30 June 2022 – Multitude SE (ISIN: FI4000106299, WKN: A1W9NS) (“Multitude” or the “Group”) announces that the ESG policy has been published on the Group’s website today. Multitude has published its first ESG policy as part of implementation of the ESG strategy defined in the 4th quarter of 2021. In March this year, the Group published its first ESG Report under the new Group strategy, outlining 2025 ESG goals. The Group ESG policy describes the Group’s management of ESG and sustainability matters and supports the delivery of the 2025 ESG goals which include the ambition to embed ESG conscious practices. The Group ESG policy incorporates, amongst others, the new Environmental policy describing commitments to managing environmental impacts and a description of the ESG Risk Management...

PLANO, Texas, June 30, 2022 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for second quarter 2022, at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, July 28, 2022. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details:Date: Thursday, July 28, 2022 Time: 8 a.m. CT / 9 a.m. ET Domestic dial-in number: (888) 330-3567 International dial-in number: (646) 960-0842 Conference ID: 9252310 Webcast Registration: ITGR Q2 2022 Earnings CallAn audio replay will be available for 7 days and can be accessed by dialing (800) 770-2030 or (647) 362-9199 and using Conference...

LONDON, June 30, 2022 (GLOBE NEWSWIRE) — Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced the appointment of James Taylor as Chief Business Officer and Cassian Yee, MD to its Scientific Advisory Board (SAB), effective July 1, 2022. James brings over 25 years of value-creating deal experience that includes global platform and asset deals for pharmaceutical and biotechnology companies. Most recently, he was Chief Business Officer at Sosei Heptares, where he completed a major collaboration with Neurocrine Biosciences for a Phase II-ready M4 agonist for schizophrenia, and led deals with Genentech, Takeda, AbbVie, GSK, Verily, Aditum and Biohaven Pharmaceuticals. Prior to this, James was a senior director at GSK where he...

ARLINGTON, Va., June 30, 2022 (GLOBE NEWSWIRE) — Edge Total Intelligence Inc. (“edgeTI”) and SD3IT, an industry leading provider of complex information technology solutions to the federal government, have partnered to bring comprehensive situational awareness solutions to SD3IT’s federal customers via edgeTI’s real-time digital operations platform edgeCore™. Building upon the collaborative work conducted at TechNet’s Indo Pacific Spring Conference held last month in Honolulu, SD3IT moved forward to add edgeCore to its extensive portfolio of data centricity, cloud, and cyber solutions. Considering the dynamic, pervasive challenges faced by government and industry, SD3IT understands the importance of engineering real-time digital capabilities that increase situational awareness, increase responsiveness, and increase efficiency...

§  Biomarker data correlates with clinical data announced in January 2022 §  46 patient open label extension being opened to support US FDA EUA application  New York, NY, and Tel Aviv, ISRAEL, June 30, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced biomarker data from its majority-owned joint venture 3CL Pharma Ltd.’s Phase 2 clinical trial of Tollovir™ in hospitalized COVID-19 patients. The data showed a positive correlation between the clinical data announced for Tollovir on January 27, 2022 and biomarkers associated with acute phase immune response (IL-6), inflammation (C reactive protein), blood clotting (D-dimer) and immune response to COVID-19 (cPass neutralizing antibodies). Additionally, renal and hepatic...

SAN JOSE, Calif., June 30, 2022 (GLOBE NEWSWIRE) — Nubeva Technologies (TSX-V: NBVA, OTC: NBVAF), a pioneer of next-generation solutions for ransomware, announces a strategic partnership with Arcas Risk Management, Inc., a leading cyber risk management firm that specializes in bringing quality services, historically reserved for large firms, to small and mid-sized organizations. “As a part of a live response engagement, we deployed Nubeva to protect against ransomware reinfection, which is common when restoring systems from back-ups,” said Robert Fitzgerald, CEO of Arcas Risk Management. “Arcas Risk was able to get the customer back online quickly and with greater assurance for our customer. Following the engagement, we sold the customer on a network-wide deployment to protect against future ransomware attacks and hope to repeat...

CHICAGO, June 30, 2022 (GLOBE NEWSWIRE) — Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats” or the “Company”), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, today announced the expiration and results of its previously announced exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) relating to its outstanding public warrants to purchase shares of its Class A common stock, par value $0.0001 per share (“Class A Common Stock”). The Offer and Consent Solicitation expired at 11:59 p.m., Eastern Daylight Time, on June 29, 2022. The Company has been advised that 11,366,727 public warrants, or approximately 62.7% of the outstanding public warrants, were validly tendered and not validly...